Regenxbio (RGNX) Cash from Investing Activities Growth (5y) (2020 - 2025)
Regenxbio (RGNX) Cash from Investing Activities Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Regenxbio | 501.81 Mn | 271.74 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.54% |
| Sep 30, 2025 | 4.46% |
| Jun 30, 2025 | -38.83% |
| Mar 31, 2025 | 6.47% |
| Dec 31, 2024 | 23.26% |
| Sep 30, 2024 | -0.78% |
| Jun 30, 2024 | -15.01% |
| Mar 31, 2024 | 19.27% |
| Dec 31, 2023 | 20.17% |
| Sep 30, 2023 | 17.95% |
| Jun 30, 2023 | 28.02% |
| Mar 31, 2023 | 29.92% |
| Dec 31, 2022 | 90.91% |
| Sep 30, 2022 | 23.10% |
| Jun 30, 2022 | 46.89% |
| Mar 31, 2022 | -98.27% |
| Dec 31, 2021 | -70.50% |
| Sep 30, 2021 | 10.44% |
| Jun 30, 2021 | 21.94% |
| Mar 31, 2021 | -81.96% |